- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02917668
Evaluation of the Risk of Hyperoxia-induced Hypercapnia in Obese Cardiac Surgery Patients
Evaluation of the Risk of Hyperoxia-induced Hypercapnia in Obese Patients in a Cardiac Surgery Postoperative Setting
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study aims to evaluate the risk of hyperoxia-induced hypercapnia in post-op obese cardiac surgery patients.
The investigators will compare two oxygenation modes in terms of their effect on PaCO2 : a SpO2 target of > or = 95 % achieved with manual titration (usual practice) and a more conservative SpO2 target of 90 % achieved with automatic titration by a closed-loop system (FreeO2).
The choice of a SpO2 target of 90 % is consistent with recent guidelines issued by the British Thoracic Society and the Thoracic Society of Australia and New Zealand, which both recommend a SpO2 target of 88-92 % for morbidly obese patients (BMI > 40 kg/m2).
FreeO2 is a closed-loop oxygen delivery system which adjusts the oxygen flow according to the patient's real-time SpO2 and a target programed by the physician. The system also records data on heart rate, respiratory rate and SpO2. Its safety and efficacy have been tested in healthy subjects as well as in patients suffering from COPD or acute respiratory distress in the emergency room, with promising results.
The research hypothesis is that the usual SpO2 target of > or = 95 % is associated with a greater PaCO2 compared with a lesser SpO2 target of 90%.
30 obese patients will be recruited* at the Institut universitaire de cardiologie et de pneumologie de Québec. A written consent from the patient will be obtained the day before the surgery. The protocol has been submitted to and approved by the establishment's ethics committee.
The study will compare the effect of two different oxygenation modes on the patients' PaCO2 immediately after extubation :
FreeO2 mode : oxygen delivered by nasal cannula or Venturi mask (if flow > 5L/min during > 5 minutes), automatically titrated for a SpO2 of 90 +/- 2 %
Usual mode : oxygen delivered by Venturi mask, manually titrated for a SpO2 superior or equal to 95 % (the local protocol is to deliver a post-extubation FiO2 which is 10 % superior to the pre-extubation FiO2)
Patients meeting all of the eligibility criteria will be randomized in the postoperative period. After extubation, they will receive oxygen for 30 minutes according to FreeO2 mode or the usual mode, depending on randomization. After 30 minutes, a first arterial blood gas will be obtained through their arterial cannula. Next, they will be oxygenated according to the second oxygenation mode for another 30 minutes, after which a second arterial blood gas will be obtained. Each patient will thus act as his own control (cross-over design).
When patients will be oxygenated according to the usual mode, FreeO2 will be in recording mode, but will not be delivering any oxygen.
The study will last 1h for each patient, and will have to begin within 30 minutes after extubation. A member of the research team will be at the patient's bedside for the whole data collecting period.
Complete data collection should be achieved within 12 months.
Demographic data (age, sex, weight, height and BMI) will be collected upon study entering as well as pre-operative room air PCO2 on capillary blood gas, type of surgery (number of bypass grafts, extracorporal circulation time), opiates dosage per-op and post-op, and pre-op left ventricular ejection fraction and renal function. FreeO2 will be recording respiratory rate, heart rate and SpO2 for the whole study duration. The respiratory rate will also be recorded manually and on the monitor. When patients will be receiving oxygen from FreeO2, the system will record the delivered flow ; with the usual mode, the staff will record the delivered FiO2. At the end of each intervention, hemodynamic measures will be taken : systolic, diastolic and median arterial blood pressure, systolic, diastolic and median pulmonary artery pressure and amine level.
*Initially, 15 patients were supposed to be included. After inclusion of those 15 patients, statistical analyses showed a lack of statistical power and a possibly significant difference in PaCO2, but only in half the patients. We thus submitted a protocol amendment to our institution's ethics committee to enlarge the sample size to 30 patients, which was accepted on July 13th, 2017.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Québec, Canada, G1V4G5
- Institut Universitaire De Cardiologie Et De Pneumologie De Québec
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI > 30 kg/m2
- SpO2 > or = 95 % before extubation
- Procedure : coronary artery bypass
Exclusion Criteria:
- Comorbidities : chronic obstructive pulmonary disease, cystic fibrosis, restrictive syndrome not associated with obesity (pulmonary fibrosis, neuromuscular junction disease, etc.)
- Obstructive sleep apnea requiring a positive-pressure mask in the posteoperative period
- FreeO2 device unavailable
- Inclusion in another study that does not permit dual inclusion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group A
15 patients who will receive usual care for 30 minutes and then switch to FreeO2 for another 30 minutes
|
Oxygen delivery automatically titrated by a closed-loop system that adjusts the oxygen flow based on the patient's real-time SpO2 and a programed SpO2 target of 90 %
Oxygen delivery manually titrated by the nursing staff for a SpO2 target of > or = 95 %
|
Active Comparator: Group B
15 patients who will be oxygenated by FreeO2 for 30 minutes and then switch to usual care for another 30 minutes
|
Oxygen delivery automatically titrated by a closed-loop system that adjusts the oxygen flow based on the patient's real-time SpO2 and a programed SpO2 target of 90 %
Oxygen delivery manually titrated by the nursing staff for a SpO2 target of > or = 95 %
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference in PaCO2
Time Frame: At 30 minutes (first intervention) and at 1h (second intervention)
|
Difference in end-of-period PaCO2 on arterial blood gas
|
At 30 minutes (first intervention) and at 1h (second intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference in pH
Time Frame: At 30 minutes (first intervention) and at 1h (second intervention)
|
Difference in end-of-period pH on arterial blood gas
|
At 30 minutes (first intervention) and at 1h (second intervention)
|
Difference in PaO2
Time Frame: At 30 minutes (first intervention) and at 1h (second intervention)
|
Difference in end-of-period PaO2 on arterial blood gas
|
At 30 minutes (first intervention) and at 1h (second intervention)
|
Difference in percentage of time spent in hypoxemia (SpO2 < 88%)
Time Frame: In the first 30 minutes (first intervention) and between 30 min and 1h (second intervention)
|
Difference in percentage of time spent in hypoxemia (SpO2 < 88%) between periods
|
In the first 30 minutes (first intervention) and between 30 min and 1h (second intervention)
|
Difference in percentage of time spent in severe hypoxemia (SpO2 < 85 %)
Time Frame: In the first 30 minutes (first intervention) and between 30 min and 1h (second intervention)
|
Difference in percentage of time spent in severe hypoxemia (SpO2 < 85 %) between periods
|
In the first 30 minutes (first intervention) and between 30 min and 1h (second intervention)
|
Difference in percentage of time spent in hyperoxemia (SpO2 > 96 %)
Time Frame: In the first 30 minutes (first intervention) and between 30 min and 1h (second intervention)
|
Difference in percentage of time spent in hyperoxemia (SpO2 > 96 %) between periods
|
In the first 30 minutes (first intervention) and between 30 min and 1h (second intervention)
|
Difference in respiratory rate (manual and monitor)
Time Frame: At 0, 10, 20, 30, 40, 50 and 60 minutes
|
Difference in respiratory rate (manual, monitor, FreeO2) between periods for each measuring technique (manual and monitor)
|
At 0, 10, 20, 30, 40, 50 and 60 minutes
|
Difference in mean heart rate
Time Frame: In the first 30 minutes and between 30 and 60 minutes
|
Difference in mean heart rate, recorded continuously by FreeO2, between periods
|
In the first 30 minutes and between 30 and 60 minutes
|
Difference in arterial blood pressure
Time Frame: At 0, 10, 20, 30, 40, 50 and 60 minutes
|
Difference in arterial blood pressure (systolic, diastolic and mean) between periods
|
At 0, 10, 20, 30, 40, 50 and 60 minutes
|
Difference in pulmonary artery pressure
Time Frame: At 0, 10, 20, 30, 40, 50 and 60 minutes
|
Difference in pulmonary artery pressure (systolic, diastolic and mean) between periods
|
At 0, 10, 20, 30, 40, 50 and 60 minutes
|
Difference in vasopressor dosage
Time Frame: At 0, 10, 20, 30, 40, 50 and 60 minutes
|
Difference in vasopressor dosagel at different times between periods
|
At 0, 10, 20, 30, 40, 50 and 60 minutes
|
Difference in body temperature
Time Frame: At 0, 10, 20, 30, 40, 50 and 60 minutes
|
Difference in body temperature at different times between periods
|
At 0, 10, 20, 30, 40, 50 and 60 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: François Lellouche, MD, PhD, Laval University
Publications and helpful links
General Publications
- Lellouche F, L'her E. Automated oxygen flow titration to maintain constant oxygenation. Respir Care. 2012 Aug;57(8):1254-62. doi: 10.4187/respcare.01343. Epub 2012 Feb 17.
- O'Driscoll BR, Howard LS, Davison AG; British Thoracic Society. BTS guideline for emergency oxygen use in adult patients. Thorax. 2008 Oct;63 Suppl 6:vi1-68. doi: 10.1136/thx.2008.102947. No abstract available. Erratum In: Thorax. 2009 Jan;64(1):91.
- Beasley R, Chien J, Douglas J, Eastlake L, Farah C, King G, Moore R, Pilcher J, Richards M, Smith S, Walters H. Thoracic Society of Australia and New Zealand oxygen guidelines for acute oxygen use in adults: 'Swimming between the flags'. Respirology. 2015 Nov;20(8):1182-91. doi: 10.1111/resp.12620.
- Denault MH, Ruel C, Simon M, Bouchard PA, Simard S, Lellouche F. Evaluation of hyperoxia-induced hypercapnia in obese patients after cardiac surgery: a randomized crossover comparison of conservative and liberal oxygen administration. Can J Anaesth. 2020 Feb;67(2):194-202. doi: 10.1007/s12630-019-01500-x. Epub 2019 Oct 24.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21366
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
-
University of HoustonBaylor College of MedicineCompleted
Clinical Trials on FreeO2
-
University Hospital, BrestCompletedMajor Thoracic and Abdominal SurgeryFrance, Canada
-
François LelloucheUnknownSurgery | COPD Exacerbation | Abdominal Obesity | Oxygen ToxicityCanada
-
Laval UniversityUnknownPneumonia | Respiratory Failure | Asthma | COPD Exacerbation | Respiratory DiseaseCanada
-
Laval UniversityRecruitingCOPD Exacerbation | Hypoxemia | Hyperoxia | Oxygen Toxicity | Hypoxic Respiratory FailureCanada
-
University Hospital, BrestMinistry of Health, FranceCompletedAcute Respiratory Distress Syndrome | HypoxemiaFrance, Canada
-
University Hospital, BrestCompletedHypoxemic Acute Respiratory Distress | Infant Between 1 Month and 24 Months Old | Child Between 2 and 15 Years OldFrance
-
University Hospital, BrestTerminated
-
François LelloucheOttawa Hospital Research Institute; The Ottawa HospitalUnknownTrauma | COPD Exacerbation
-
Laval UniversityNot yet recruitingCOVID-19 | Hypoxia | Hypoxemia | HyperoxiaCanada
-
Laval UniversityUnknownPneumonia | Coronavirus | Oxygen ToxicityCanada